Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

441 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health diplomacy in action: The cancer legacy of the Good Friday Agreement.
Lawler M, Sullivan R, Abou-Alfa GK, McCloskey K, Keatley D, Feighan J, Dahut W, Mulroe E, Ladner R, Genead M, Lowery M, Gulley JL, Scott CJ, Longley DB, Culhane A, Gallagher WM, Orr N, Chanock SJ, Gopal S. Lawler M, et al. J Cancer Policy. 2023 Dec;38:100448. doi: 10.1016/j.jcpo.2023.100448. Epub 2023 Oct 14. J Cancer Policy. 2023. PMID: 37839622 Free article.
Impact of the COVID-19 pandemic on cancer care in Ireland - Perspectives from a COVID-19 and Cancer Working Group.
O'Reilly S, Kathryn Carroll H, Murray D, Burke L, McCarthy T, O'Connor R, Kilty C, Lynch S, Feighan J, Cloherty M, Fitzpatrick P, Falvey K, Murphy V, Jane O'Leary M, Gregg S, Young L, McAuliffe E, Hegarty J, Gavin A, Lawler M, Kavanagh P, Spillane S, McWade T, Heffron M, Ryan K, Kelly PJ, Murphy A, Corrigan M, Redmond HP, Redmond P, Walsh PM, Tierney P, Zhang M, Bennett K, Mullooly M. O'Reilly S, et al. Among authors: lawler m. J Cancer Policy. 2023 Jun;36:100414. doi: 10.1016/j.jcpo.2023.100414. Epub 2023 Feb 24. J Cancer Policy. 2023. PMID: 36841473 Free PMC article. Review.
The rise of immuno-oncology in China: a challenge to western dominance?
Lythgoe MP, Lewison G, Aggarwal A, Booth C, Lawler M, Trapani D, Sengar M, Sullivan R. Lythgoe MP, et al. Among authors: lawler m. Lancet Oncol. 2023 May;24(5):439-441. doi: 10.1016/S1470-2045(23)00026-8. Lancet Oncol. 2023. PMID: 37142369 No abstract available.
Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach.
Henderson RH, French D, Stewart E, Smart D, Idica A, Redmond S, Eckstein M, Clark J, Sullivan R, Keeling P, Lawler M. Henderson RH, et al. Among authors: lawler m. J Pharm Policy Pract. 2023 Jul 5;16(1):84. doi: 10.1186/s40545-023-00590-9. J Pharm Policy Pract. 2023. PMID: 37408046 Free PMC article.
surviveR: a flexible shiny application for patient survival analysis.
Sessler T, Quinn GP, Wappett M, Rogan E, Sharkey D, Ahmaderaghi B, Lawler M, Longley DB, McDade SS. Sessler T, et al. Among authors: lawler m. Sci Rep. 2023 Dec 13;13(1):22093. doi: 10.1038/s41598-023-48894-9. Sci Rep. 2023. PMID: 38086891 Free PMC article.
441 results